The FDA has granted orphan drug designation to onvansertib as a potential treatment for CMML, a form of blood cancer.
Columnist and caregiver Samuel Ike shares his strategy of honestly and lovingly talking to his mother when there's bad news ...
A treatment regimen using Zenbexus can reduce the risk of disease progression in people with hard-to-treat multiple myeloma, ...
An experimental treatment containing two naturally occurring pancreatic enzymes may be able to reduce the growth of cancer, a ...
An EU committee is urging that an approved myeloma drug also be cleared for use as part of a combo treatment after a ...
When a sudden wave of exhaustion washes over columnist Gina Diamante, the thought of a multiple myeloma relapse comes rushing in, too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results